Multiple hospitals are holding talks with suppliers! Corruption in pharmaceutical procurement and sales attracts attention
2024-09-05
The deepening of anti-corruption in the pharmaceutical industry has attracted widespread attention to corruption in the pharmaceutical procurement and sales sector, and hospitals have become increasingly strict in their requirements for procurement and sales processes. Recently, multiple hospitals have held talks with medical consumables suppliers, including some tertiary hospitals. According to public information and incomplete statistics from Zhongxin Health, since July, more than 30 hospitals have interviewed representatives of pharmaceutical and equipment suppliers, with a total of over 2000 interviewees. Many hospitals have signed "Integrity Agreements for Purchase and Sale" with supplier representatives on site. On August 30th, representatives of pharmaceutical and equipment suppliers were interviewed by multiple hospitals. The Second People's Hospital of Zhoushan City, Zhejiang Province held a collective anti-corruption talk for suppliers in 2024, emphasizing the need to deeply understand the high-pressure situation of anti-corruption work in the pharmaceutical industry and the punishment power of disciplinary inspection and supervision agencies for bribery. It is necessary to resolutely eliminate unfair competition behaviors such as collusion and bid rigging, as well as any "hunting" behavior that may affect the integrity of hospital cadres and staff. On August 23rd, the main responsible persons of the affiliated tumor hospital of Xiangya Medical College, Central South University, and eight agency companies that have bidding and cooperation relationships with the hospital held a collective anti-corruption talk. The talk mentioned that as a partnership between each agency company and the hospital, they cannot pay the price of their future just because of a "one shot" deal. Both bidding agencies and bidding management departments should carry out their work within the framework of law and discipline, and only in this way can they achieve stability and long-term success. On July 24th and August 2nd, the Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine organized collective anti-corruption talks with more than 200 companies including drug distribution enterprises, consumables suppliers, third-party companies, and bidding agencies, proposing to strictly prohibit bundling sales and "cash sales" under various forms of meetings, donations, scientific research cooperation, and experimental promotion; It is strictly prohibited to demand kickbacks from medical personnel during procurement, sales, and use. In addition, several tertiary hospitals, including Fujian University of Traditional Chinese Medicine Affiliated Rehabilitation Hospital, Yinchuan First People's Hospital, and Kunming Medical University Second Affiliated Hospital, have recently held talks with suppliers of medical equipment and consumables. Corruption in the procurement and use of medical equipment and consumables has attracted attention. According to a previous report by China News Health, several provinces have recently released audit reports on budget execution and other financial revenues and expenditures for the year 2023. Among the issues related to the medical and health field mentioned in multiple audit reports, the bidding, procurement, and use of medical equipment and consumables occupy an important part. Data picture: Various surgical instruments are placed on the table. For example, audit reports from multiple provinces such as Zhejiang and Anhui have mentioned issues such as formalism and false bidding in the bidding and procurement of medical equipment in public hospitals. Some bidding and procurement projects involve amounts of hundreds of millions of yuan. There are also audit reports mentioning that some suppliers bundle and sell consumables and drugs to hospitals through providing equipment for free or selling equipment at low prices, disrupting market order. The field of bidding has always been a high-risk area for corruption. The Third Plenary Session of the 20th Central Commission for Discipline Inspection pointed out in deploying this year's key work that it is necessary to deepen the rectification of corruption in areas such as finance, state-owned enterprises, energy, tobacco, medicine, infrastructure projects, and bidding where power is concentrated, funds are intensive, and resources are abundant. Multiple regions have launched special audits to verify the "bills" for the purchase and sale of drugs and medical devices in public hospitals, which are also being intensively promoted and are not limited to within medical institutions. The production, distribution, and use of drugs and medical devices are all key areas of inspection. Notice from the Audit Office of Zhejiang Province on Special Audit Investigation of Public Hospitals and the Production, Distribution, and Use of Drugs and Medical Devices. The Notice on Special Audit Investigation of Public Hospitals and the Production, Distribution and Use of Drugs and Medical Devices issued by the Audit Office of Zhejiang Province on September 2 stated that from September 5, special audit investigations will be conducted on the production, distribution and use of public hospitals and drugs and medical devices, and if necessary, they will be traced back to relevant years or extended to audit relevant units. On August 29th, the Audit Department of Yunnan Province issued an audit notice on conducting a special audit investigation on the production, distribution, and use of public hospitals and drugs and medical devices. According to the plan, the on-site audit work is expected to start in early September this year and be completed before November 4th. This special audit covers the production, distribution, and use of drugs and medical devices in public hospitals such as Qujing, Honghe, Pu'er, Dali Prefecture (City) People's Government, Yunnan Third People's Hospital, and Kunming Medical University Third Affiliated Hospital from January 2022 to June 2024. With the assistance of auditing, more hidden chaos in the pharmaceutical industry may be exposed. (New Society)
Edit：Lubaikang Responsible editor：Chenze
Source：chinanews.com
Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email：lwxsd@liaowanghn.com
Recommended Reading Change it 
Home
